Across TCGA pan-cancer cohorts, GOLGA6L16P RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of GOLGA6L16P’s most consistent transcriptional readouts.

The strongest signal is observed in lung squamous cell carcinoma (LUSC), where GOLGA6L16P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types GOLGA6L16P is over-expressed in tumor.

LUSC and PRAD are the cancer types where GOLGA6L16P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in GOLGA6L16P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LUSC	Male	All	+0.036	.027	2	view →
PRAD	All	All	+0.008	.019	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: GOLGA6L16P RNA expression & survival · all GOLGA6L16P data types